2019
Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance
Higgins-Chen AT, Abdallah SB, Dwyer JB, Kaye AP, Angarita GA, Bloch MH. Severe Illness Anxiety Treated by Integrating Inpatient Psychotherapy With Medical Care and Minimizing Reassurance. Frontiers In Psychiatry 2019, 10: 150. PMID: 30967801, PMCID: PMC6438952, DOI: 10.3389/fpsyt.2019.00150.Peer-Reviewed Case Reports and Technical NotesHealth concernPsychiatric careMedical careCo-morbid hypertensionOutpatient medical visitsHigher healthcare utilizationNumerous health concernsClinical symptom scalesCognitive-behavioral therapy protocolIllness anxiety disorderMedication changesSimilar treatment plansMedication regimenOutpatient managementHealthcare utilizationMedical visitsCase reportInpatient hospitalizationEmergency roomVitamin deficiencyHospitalization criteriaProvider teamOutpatient providersManaging medicationsSymptom Scale
2008
Riluzole in the Treatment of Mood and Anxiety Disorders
Pittenger C, Coric V, Banasr M, Bloch M, Krystal JH, Sanacora G. Riluzole in the Treatment of Mood and Anxiety Disorders. CNS Drugs 2008, 22: 761-786. PMID: 18698875, DOI: 10.2165/00023210-200822090-00004.Peer-Reviewed Original ResearchConceptsTreatment of moodAnxiety disordersMultiple molecular actionsOpen-label trialPlacebo-controlled trialAmino acid neurotransmissionCommon adverse effectsLiver function testsAmyotrophic lateral sclerosisVoltage-gated sodium channelsBorderline personality disorderSelf-injurious behaviorStandard therapyIll patientsBipolar depressionFunction testsObsessive-compulsive disorderCase reportGlutamatergic neurotransmissionGlutamate levelsExtracellular glutamateClinical consequencesLateral sclerosisAstrocytic uptakeRiluzole